Effect of Pravastatin in People with Diabetes and Chronic Kidney Disease-Reference-Cited by-同舟云学术

Effect of Pravastatin in People with Diabetes and Chronic Kidney Disease

Published:2005-10-26 Issue:12 Volume:16 Page:3748-3754
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Tonelli Marcello,Keech Anthony,Shepherd Jim,Sacks Frank,Tonkin Andrew,Packard Chris,Pfeffer Marc,Simes John,Isles Chris,Furberg Curt,West Malcolm,Craven Tim,Curhan Gary

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference36 articles.

1. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease

2. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial

3. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease

4. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between statin use and diabetic nephropathy in US adults: data from NHANES 2005 - 2018;Frontiers in Endocrinology;2024-04-25

2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

3. Tachykinins Play a Major Role in Micro and Macrovascular Complications in Type 2 Diabetes Patients;Current Diabetes Reviews;2023-05-05

4. Insights into the Association of Chronic Kidney Disease (CKD) and Cardiovascular Risk Among Diabetic vs Non-Diabetic Patients;Cardiovascular & Hematological Agents in Medicinal Chemistry;2023-03

5. Antidyslipidemia Pharmacotherapy in Chronic Kidney Disease: A Systematic Review and Bayesian Network Meta-Analysis;Pharmaceutics;2022-12-20